Eli Lilly (LLY)
813.53
-0.00 (-0.00%)
NYSE · Last Trade: Oct 30th, 9:05 AM EDT
Eli Lilly's Q3 2025 results crushed estimates, driven by high demand for Mounjaro and Zepbound. The company raised its full-year outlook, sparking a stock rally.
Via Chartmill · October 30, 2025
Shares jumped early Thursday after the drugmaker easily topped third-quarter forecasts.
Via Investor's Business Daily · October 30, 2025
Global pharmaceutical company Eli Lilly (NYSE:LLY) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 53.9% year on year to $17.6 billion. The company’s full-year revenue guidance of $63.25 billion at the midpoint came in 2.6% above analysts’ estimates. Its non-GAAP profit of $7.02 per share was 18.6% above analysts’ consensus estimates.
Via StockStory · October 30, 2025
The global stock market is currently navigating an unprecedented era of record-breaking growth in late October 2025, a phenomenon largely orchestrated by the remarkable performance and pervasive influence of the technology sector, with Artificial Intelligence (AI) at its core. Major U.S. indices, including the S&P 500, Dow Jones Industrial Average, and Nasdaq Composite, have consistently [...]
Via TokenRing AI · October 29, 2025
Santa Clara, CA – October 29, 2025 – In a historic moment for the technology sector, Nvidia (NASDAQ: NVDA) has officially achieved an unprecedented $5 trillion market capitalization, becoming the first publicly traded company to reach this staggering valuation. This monumental milestone, reached on Wednesday, October 29, 2025, underscores Nvidia's indispensable role
Via MarketMinute · October 29, 2025
In a historic moment for the technology and financial worlds, Nvidia Corporation (NASDAQ: NVDA) officially achieved an unprecedented $5 trillion market capitalization on Wednesday, October 29, 2025. This landmark valuation, reached during early market trading as shares surged, solidifies Nvidia's position as the world's most valuable company and underscores the profound and accelerating dominance of [...]
Via TokenRing AI · October 29, 2025
Eli Lilly partners with NVIDIA to build a powerful AI supercomputer and teams up with Walmart to expand affordable Zepbound access nationwide.
Via Benzinga · October 29, 2025
Two Nvidia Shockers Please click here for an enlarged chart of NVIDIA Corp (NASDAQ:NVDA).
Via Benzinga · October 29, 2025
Nvidia (NASDAQ: NVDA) stands as the undisputed titan of the artificial intelligence (AI) era, its stock performance a primary catalyst for the recent, unprecedented surge in global financial markets. As of October 29, 2025, the company's valuation has soared to a historic $5 trillion, a milestone unmatched by any public
Via MarketMinute · October 29, 2025
Zepbound vials will be offered for pick-up at Walmart pharmacies nationwide by mid-November.
Via Stocktwits · October 29, 2025
It offers compelling weight-loss drugs -- and a compelling stock price, too.
Via The Motley Fool · October 29, 2025
This stock has caught fire after some recent events, but how long will that last?
Via The Motley Fool · October 29, 2025
Global pharmaceutical company Eli Lilly (NYSE:LLY)
will be announcing earnings results this Thursday before market open. Here’s what investors should know.
Via StockStory · October 28, 2025
This momentary pullback represents an excellent opportunity to buy this high-flying stock.
Via The Motley Fool · October 28, 2025
The Nvidia-powered system aims to cut drug development times and boost innovation.
Via Talk Markets · October 28, 2025
Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA)
jumped 5.2% in the afternoon session after CEO Jensen Huang laid out an overwhelmingly bullish case for the company's future at a landmark GTC keynote in Washington, D.C.
Via StockStory · October 28, 2025
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO)
jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's expectations.
Via StockStory · October 28, 2025
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women.
Via Benzinga · October 28, 2025
These two have been neglected by Wall Street too much.
Via The Motley Fool · October 28, 2025
Eli Lilly (LLY) is a top growth momentum stock with accelerating earnings, strong technical ratings, and a positive breakout setup for investors.
Via Chartmill · October 28, 2025
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the market. While specific daily performance metrics remain unreleased, today's trading likely saw the sector reacting to a
Via MarketMinute · October 27, 2025
BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares
Via The Motley Fool · October 27, 2025